Find

Department of Clinical Medicine

Medical/Steno Aarhus Research Laboratory

Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Wichaidit, B. T., Rask, C. U. & Østergaard, J. R. (2014). Diagnostik af funktionelle anfald hos børn. Ugeskrift for Læger, 176, Article V10130613.

Wichaidit, B. T., Rask, C. U. & Østergaard, J. R. (2014). Diagnostik af funktionelle anfald hos børn og unge. Ugeskrift for Læger. http://ugeskriftet.dk/videnskab/diagnostik-af-funktionelle-anfald-hos-boern-og-unge

Yuen, K. C. J., Roberts, C. T., Frystyk, J., Rooney, W. D., Pollaro, J. R., Klopfenstein, B. J. & Purnell, J. Q. (2014). Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism, 99(10), E1862-9. https://doi.org/10.1210/jc.2014-1532

Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., Arima, H., Monaghan, H., Joshi, R., Colagiuri, S., Cooper, M. E., Glasziou, P., Grobbee, D., Hamet, P., Harrap, S., Heller, S., Lisheng, L., Mancia, G., Marre, M. ... the ADVANCE-ON Collaborative Group (2014). Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes. The New England Journal of Medicine, 371(15), 1392-1406. https://doi.org/10.1056/NEJMoa1407963

Andreassen, M., Frystyk, J., Faber, J., Kristensen, L. Ø. & Juul, A. (2013). Growth hormone (GH) activity is associated with increased serum oestradiol and reduced Anti-Müllerian Hormone in healthy male volunteers treated with GH and a GH antagonist. Andrology, 1(4), 595-601. https://doi.org/10.1111/j.2047-2927.2013.00096.x

Andries, A., Frystyk, J., Flyvbjerg, A. & Støving, R. K. (2013). Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial. International Journal of Eating Disorders, 47(1), 18-23. https://doi.org/10.1002/eat.22173

Arjona Ferreira, J. C., Corry, D., Mogensen, C. E., Sloan, L., Xu, L., Golm, G. T., Gonzalez, E. J., Davies, M. J., Kaufman, K. D. & Goldstein, B. J. (2013). Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. American Journal of Kidney Diseases, 61(4), 579-87. https://doi.org/10.1053/j.ajkd.2012.11.043

Bach, E., Nielsen, B. R. R., Vendelbo, M. H., Møller, A. B., Jessen, N., Buhl, M., Hafstrøm, T. K., Holm, L., Pedersen, S. B., Pilegaard, H., Biensø, R. S., Jørgensen, J. O. L. & Møller, N. (2013). Direct effects of TNF-α on local fuel metabolism and cytokine levels in the placebo controlled bilaterally infused human leg; increased insulin sensitivity, increased net protein breakdown and increased IL-6 release. Diabetes. https://doi.org/10.2337/db13-0138

Bjerre, M., Pedersen, S. F., Møgelvang, R., Lindberg, S., Jensen, J., Galatius, S. & Flyvbjerg, A. (2013). High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention. European Journal of Preventive Cardiology, 20(6), 922-9. https://doi.org/10.1177/2047487313487083

Bjerre, M. (2013). Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications. SpringerPlus, 2, 658. https://doi.org/10.1186/2193-1801-2-658

Displaying results 2621 to 2630 out of 4099

263

Revised 11.09.2025

-

Department of Clinical Medicine